Optiver Holding
LENZ

Optiver Holding’s LENZ Therapeutics LENZ Stock Holding History

Optiver Holding’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$398 Sell
70
-72
-51% -$580 ﹤0.01% 2586
2026
Q1 		$1.3K Hold
142
– – ﹤0.01% 2002
2025
Q4 		$2.27K Hold
142
– – ﹤0.01% 1945
2025
Q3 		$6.61K Buy
+142
New +$5.22K ﹤0.01% 1538

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Optiver Holding's LENZ Position: Q2 2026 in Review

Optiver Holding reduced its LENZ Therapeutics (LENZ) stake by 51% in Q2 2026, selling an estimated $580 and leaving 70 shares worth $398. The position accounts for ﹤0.01% of the portfolio, ranked #2586.

Optiver Holding first reported a position in LENZ in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.61K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Optiver Holding held 70 shares of LENZ Therapeutics worth $398 as of Q2 2026.
  • Optiver Holding sold 72 LENZ Therapeutics shares in Q2 2026, an estimated $580.
  • LENZ Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2586 holding.
  • Optiver Holding first reported a position in LENZ Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's LENZ Therapeutics position peaked at $6.61K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.